戸井 雅和 とい まさかず 先生

来歴等

略歴

1982年 広島大学医学部 卒業
1990年 英国Oxford 大学分子医学研究所・Oxford大学附属John-Radcliffe Hospital 臨床腫瘍学部門 留学
1992年 東京都立駒込病院 外科 医師
2007年 京都大学大学院医学研究科 外科学講座乳腺外科学 教授
2023年 京都大学大学院医学研究科 外科学講座 退官
2023年 東京都立駒込病院 院長

論文

• Characterisation of the HLA-DRB1*07:01 biomarker for lapatinib-induced liver toxicity during treatment of early-stage breast cancer patients with lapatinib in combination with trastuzumab and/or taxanes. Pharmacogenomics J. 2017 Aug 8. doi: 10.1038/tpj.2017.39. [Epub ahead of print]

  Pharmacogenomics J. 2017 Aug 8. doi: 10.1038/tpj.2017.39. [Epub ahead of print]

• Anti-Tumor Activity and Immunotherapeutic Potential of a Bisphosphonate Prodrug.Sci Rep. 2017 Jul 20;7(1):5987. doi: 10.1038/s41598-017-05553-0.

  Tanaka Y, et al.

• Effect of dose timing on the blood concentration of lapatinib in patients with breast cancer.Ann Oncol. 2017 Jun 26. doi: 10.1093/annonc/mdx328.

  Ohgami M, et al.

• Higher breast cancer conspicuity on dbPET compared to WB-PET/CT.Eur J Radiol. 2017 May;90:138-145. doi: 10.1016/j.ejrad.2017.02.046.

  Nishimatsu K, et al.

• MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2- Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy.J Clin Oncol. 2017 Jun 3:JCO2017737585. doi: 10.1200/JCO.2017.73.7585.

  Sledge GW Jr, et al.

• Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy.N Engl J Med. 2017 Jun 1;376(22):2147-2159. doi: 10.1056/NEJMoa1612645.

  Masuda N, et al.

• Ultrafast dynamic contrast-enhanced mri of the breast using compressed sensing: breast cancer diagnosis based on separate visualization of breast arteries and veins.J Magn Reson Imaging. 2017 May 28. doi: 10.1002/jmri.25747.

  Onishi N, et al.

• Downregulation of neuropilin-1 on macrophages modulates antibody-mediated tumoricidal activity.Cancer Immunol Immunother. 2017 Apr 21. doi: 10.1007/s00262-017-2002-2.

  Kawaguchi K, et al.

• Efficacy and safety of everolimus in combination with trastuzumab and paclitaxel in Asian patients with HER2+ advanced breast cancer in BOLERO-1.Breast Cancer Res. 2017 Apr 11;19(1):47. doi: 10.1186/s13058-017-0839-0.

  Toi M, et al.

• Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial.J Clin Oncol. 2017 May 1;35(13):1421-1429. doi: 10.1200/JCO.2016.69.7722. E

  Sonnenblick A, et al.

著書

• 戸井雅和. 乳癌レビュー2012. メディカルレビュー社. 2012-12-01.

• 戸井雅和, 他. みんなに役立つ乳癌の基礎と臨床.医薬ジャーナル社.2009-07.

• Toi M, et al. Personalized Treatment of Breast Cancer. Springer Japan. 2016.

• Toi M, et al. Local and Systemic Management of Primary Breast Cancers. Kyoto University Press. 2010-04.

その他

• 【受賞】日本乳癌学会奨励賞(1995)

• 【受賞】日本乳癌学会久野賞(1998)